Paeoniflorin‐6′‐O‐Benzenesulfonate Mediates Dendritic Cell Differentiation to Alleviate Diabetic Kidney Disease

Puntos clave

• To investigate how CP-25 affects dendritic cell differentiation and its implications for diabetic kidney disease.
• Examined the effects of CP-25 on dendritic cell differentiation.
• Analyzed inflammation modulation through signaling pathways.
• Focused on GRK2-mediated JAK2-STAT3-SOCS3 signaling pathways.
• CP-25 successfully modulated dendritic cell function.
• Inhibition of inflammation was observed via the targeted signaling pathway.
• Alleviation of diabetic kidney disease symptoms was achieved.